InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Blackford Gary, Director. Director active across 3 companies, notably ReShape Lifesciences Inc.. Aggregated, 9 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €187k. History available since 22 July 2021. The latest transaction was disclosed on 27 July 2026 (Disposition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Blackford Gary
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
40,000 shares@ US$25.000.085% mcap31.2% of flowCommon StockSEC:0001606498-26-000105:0
79,590 shares@ US$25.000.17% mcap62.1% of flowCommon StockSEC:0001606498-26-000105:1
20,000 shares@ US$10.975100.0% of flowCommon StockSEC:0001606498-25-000111:0
Canonical exit: 11 Nov 2025 (T+90)
12,003 shares0Common StockSEC:0001606498-25-000016:0
8,378 shares0Common StockSEC:0001606498-24-000013:0
7,008 shares0Common StockSEC:0001606498-23-000006:0
5,354 shares0Common StockSEC:0001606498-22-000007:0
253,429 shares0Common Stock, $0.001 par value per shareSEC:0001790300-21-000008:0
4,274 sharesCommon StockSEC:0001209191-16-089552:0
9 of 9 declarations
About Blackford Gary
BLACKFORD GARY is Administrateur at Avanos Medical, INC., ReShape Lifesciences Inc., and Halyard Health, Inc. The 9 filings on record span the period from 2016-01-06 to 2026-07-28, and, across the sampled recent filings, purchases total EUR 187400 and sales total EUR 2620516.
